FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083488730> ?p ?o ?g. }

• W2083488730 endingPage "801" @default.
• W2083488730 startingPage "793" @default.
• W2083488730 abstract "Tumour-selective acidification is of potential interest for enhanced therapeutic gain of pH sensitive drugs. In this study, we investigated the feasibility of a tumour-selective reduction of the extracellular and intracellular pH and their effect on the tumour response of selected anti-cancer drugs. In an in vitro L1210 leukaemic cell model, we confirmed enhanced cytotoxicity of chlorambucil at low extracellular pH conditions. In contrast, the alkylating drugs melphalan and cisplatin, and bioreductive agents mitomycin C and its derivative EO9, required low intracellular pH conditions for enhanced activation. Furthermore, a strong and pH-independent synergism was observed between the pH-equilibrating drug nigericin and melphalan, of which the mechanism is unclear. In radiation-induced fibrosarcoma (RIF-1) tumour-bearing mice, the extracellular pH was reduced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) or its analogue benzylguanidine (BG) plus glucose. To simultaneously reduce the intracellular pH, MIBG plus glucose were combined with the ionophore nigericin or the Na+/H+ exchanger inhibitor amiloride and the Na+-dependent HCO3-/Cl- exchanger inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid (DIDS). Biochemical studies confirmed an effective reduction of the extracellular pH to approximately 6.2, and anti-tumour responses to the interventions indicated a simultaneous reduction of the intracellular pH below 6.6 for at least 3 h. Combined reduction of extra- and intracellular tumour pH with melphalan increased the tumour regrowth time to 200% of the pretreatment volume from 5.7 +/- 0.6 days for melphalan alone to 8.1 +/- 0.7 days with pH manipulation (P < 0.05). Mitomycin C related tumour growth delay was enhanced by the combined interventions from 3.8 +/- 0.5 to 5.2 +/- 0.5 days (P < 0.05), but only in tumours of relatively large sizes. The interventions were non-toxic alone or in combination with the anti-cancer drugs and did not affect melphalan biodistribution. In conclusion, we have developed non-toxic interventions for sustained and selective reduction of extra- and intracellular tumour pH which potentiated the tumour responses to selected anti-cancer drugs." @default.
• W2083488730 created "2016-06-24" @default.
• W2083488730 creator A5006115832 @default.
• W2083488730 creator A5031626684 @default.
• W2083488730 creator A5040256347 @default.
• W2083488730 creator A5041917486 @default.
• W2083488730 creator A5042649357 @default.
• W2083488730 creator A5062227574 @default.
• W2083488730 creator A5075769889 @default.
• W2083488730 date "1999-01-29" @default.
• W2083488730 modified "2023-10-10" @default.
• W2083488730 title "Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)" @default.
• W2083488730 cites W1561052663 @default.
• W2083488730 cites W1620872427 @default.
• W2083488730 cites W1801886542 @default.
• W2083488730 cites W1813541406 @default.
• W2083488730 cites W1876040716 @default.
• W2083488730 cites W1954857248 @default.
• W2083488730 cites W1956944003 @default.
• W2083488730 cites W1969735338 @default.
• W2083488730 cites W1978730527 @default.
• W2083488730 cites W1983247405 @default.
• W2083488730 cites W1987615998 @default.
• W2083488730 cites W2008082732 @default.
• W2083488730 cites W2025195895 @default.
• W2083488730 cites W2035221890 @default.
• W2083488730 cites W2067661419 @default.
• W2083488730 cites W2069310696 @default.
• W2083488730 cites W2071889003 @default.
• W2083488730 cites W2074061850 @default.
• W2083488730 cites W2075192803 @default.
• W2083488730 cites W2076207370 @default.
• W2083488730 cites W2091784285 @default.
• W2083488730 cites W2091893939 @default.
• W2083488730 cites W2095267500 @default.
• W2083488730 cites W2119434127 @default.
• W2083488730 cites W2121238780 @default.
• W2083488730 cites W2128635872 @default.
• W2083488730 cites W2131194912 @default.
• W2083488730 cites W2133832510 @default.
• W2083488730 cites W2141041167 @default.
• W2083488730 cites W2165884308 @default.
• W2083488730 cites W2170966644 @default.
• W2083488730 cites W2412446999 @default.
• W2083488730 cites W2500058840 @default.
• W2083488730 cites W4290452796 @default.
• W2083488730 cites W4293247451 @default.
• W2083488730 cites W4297945134 @default.
• W2083488730 cites W2396153597 @default.
• W2083488730 doi "https://doi.org/10.1038/sj.bjc.6690127" @default.
• W2083488730 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2362690" @default.
• W2083488730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10070871" @default.
• W2083488730 hasPublicationYear "1999" @default.
• W2083488730 type Work @default.
• W2083488730 sameAs 2083488730 @default.
• W2083488730 citedByCount "43" @default.
• W2083488730 countsByYear W20834887302012 @default.
• W2083488730 countsByYear W20834887302014 @default.
• W2083488730 countsByYear W20834887302015 @default.
• W2083488730 countsByYear W20834887302016 @default.
• W2083488730 countsByYear W20834887302017 @default.
• W2083488730 countsByYear W20834887302018 @default.
• W2083488730 countsByYear W20834887302019 @default.
• W2083488730 countsByYear W20834887302020 @default.
• W2083488730 countsByYear W20834887302021 @default.
• W2083488730 countsByYear W20834887302022 @default.
• W2083488730 crossrefType "journal-article" @default.
• W2083488730 hasAuthorship W2083488730A5006115832 @default.
• W2083488730 hasAuthorship W2083488730A5031626684 @default.
• W2083488730 hasAuthorship W2083488730A5040256347 @default.
• W2083488730 hasAuthorship W2083488730A5041917486 @default.
• W2083488730 hasAuthorship W2083488730A5042649357 @default.
• W2083488730 hasAuthorship W2083488730A5062227574 @default.
• W2083488730 hasAuthorship W2083488730A5075769889 @default.
• W2083488730 hasBestOaLocation W20834887301 @default.
• W2083488730 hasConcept C109316439 @default.
• W2083488730 hasConcept C126322002 @default.
• W2083488730 hasConcept C134897140 @default.
• W2083488730 hasConcept C178790620 @default.
• W2083488730 hasConcept C185592680 @default.
• W2083488730 hasConcept C202751555 @default.
• W2083488730 hasConcept C2776313096 @default.
• W2083488730 hasConcept C2776694085 @default.
• W2083488730 hasConcept C2777330628 @default.
• W2083488730 hasConcept C2778684742 @default.
• W2083488730 hasConcept C2779533339 @default.
• W2083488730 hasConcept C2779608910 @default.
• W2083488730 hasConcept C28406088 @default.
• W2083488730 hasConcept C41625074 @default.
• W2083488730 hasConcept C537181965 @default.
• W2083488730 hasConcept C55493867 @default.
• W2083488730 hasConcept C71924100 @default.
• W2083488730 hasConcept C79879829 @default.
• W2083488730 hasConcept C86803240 @default.
• W2083488730 hasConcept C98274493 @default.
• W2083488730 hasConceptScore W2083488730C109316439 @default.
• W2083488730 hasConceptScore W2083488730C126322002 @default.
• W2083488730 hasConceptScore W2083488730C134897140 @default.

• next